查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363005

透明質酸酶市場規模、佔有率、趨勢分析報告：按類型、用途、地區、細分趨勢，2023-2030

Hyaluronidase Market Size, Share & Trends Analysis Report By Type (Animal Derived, Synthetic), By Application (Dermatology, Chemotherapy), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

透明質酸酶市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計2030年全球透明質酸酶市場規模將達到17.346億美元，2023年至2030年年複合成長率為8.4%。

多年來，微創整容手術的重要性顯著增加，並且已經進行了各種人口統計研究來評估世界各地（尤其是已開發國家）整容手術的採用模式。

玻尿酸填充劑是世界各地進行的微創美容手術中最重要的結構要素。微創整容手術的興起預計將對市場成長產生積極影響，因為執行這些手術時主要首選透明質酸酶。皮膚填充劑在微創臉部美容手術中具有重要用途，導致報告的併發症數量不斷增加。

臨床醫師必須充分了解玻尿酸注射併發症的相關併發症，才能有效治療。建立適合緊急情況的有效行動方案至關重要，以便在手術或治療現場可以輕鬆獲得所需的藥物。這有助於控制透明質酸填充劑注射的負面影響。

透明質酸酶市場報告亮點

  • 2022 年，動物源性透明質酸酶領域佔據最大收益佔有率，達到 67.0%，預計在整個預測期內將維持這一趨勢。
  • 預計合成透明質酸酶領域在預測期內的年複合成長率將達到 9.4%，是最快的。
  • 2022 年，皮膚科細分市場佔最大銷售佔有率，約 44.6%。
  • 預計化療領域在預測期內年複合成長率最快，達 10.5%。
  • 由於新型美容療法的高普及，北美地區在 2022 年以 38.0% 的最大收益佔有率主導市場。此外，該地區的皮膚科醫生正在開發新的非手術美容手術和基於透明質酸酶的填充劑，這些在可注射真皮填充劑中受到強烈建議。
  • 由於基於透明質酸酶的療法有許多開拓的成長機會，預計亞太地區將呈現最快的成長。
  • 強大的本地製造商網路對該地區的收益做出了重大貢獻。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 透明質酸酶市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 透明質酸酶市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 透明質酸酶：類型估計與趨勢分析

  • 透明質酸酶市場：要點
  • 透明質酸酶市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 動物源性透明質酸酶
  • 合成透明質酸酶

第5章 透明質酸酶：用途估算與趨勢分析

  • 透明質酸酶市場：要點
  • 透明質酸酶市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 皮膚科
  • 化療
  • 眼科
  • 整形外科
  • 其他

第6章 透明質酸酶市場：區域估計與趨勢分析

  • 區域展望
  • 按地區分類的透明質酸酶市場：要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Amphastar Pharmaceuticals, Inc.
    • PrimaPharma, Inc.
    • Halozyme, Inc.
    • Bausch & Lomb Incorporated
    • The Cooper Companies Inc.
    • Sun Pharmaceutical Industries Ltd.
    • STEMCELL Technologies Inc.
    • Shreya Life Sciences Pvt. Ltd.
Product Code: GVR-4-68038-132-0

Hyaluronidase Market Growth & Trends:

The global hyaluronidase market size is expected to reach USD 1,734.6 million by 2030 growing at a CAGR of 8.4% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The significance of minimally invasive cosmetic procedures has increased considerably over the years and various demographic research studies have been conducted to evaluate the adoption pattern of cosmetic treatments across the globe, especially in developed countries.

Hyaluronic acid fillers form the most important component of minimally invasive aesthetic procedures carried out across the globe. Since hyaluronidase is mostly preferred while conducting these procedures, a growing number of minimally invasive aesthetic surgeries are expected to positively impact market growth. Dermal fillers have significant applications in minimally invasive facial aesthetic procedures, which has also led to an increase in the number of reported complications.

Clinicians are required to be entirely aware of the symptoms associated with hyaluronic acid injection complications in order to treat them effectively. It is crucial to establish effective protocols of action suitable for emergencies wherein the desired agents are readily available at the site of surgery or treatment. This aids in controlling the adverse impact of hyaluronic acid filler injections.

Hyaluronidase Market Report Highlights:

  • Animal derived hyaluronidase segment held the largest revenue share of 67.0% in 2022 and are anticipated to maintain this trend throughout the forecast period
  • Synthetic hyaluronidase segment is anticipated to register the fastest CAGR of 9.4% over the forecast period
  • The Dermatology segment held the largest revenue share of approximately 44.6% in 2022
  • The chemotherapy segment is estimated to register the fastest CAGR of 10.5% over the forecast period.
  • North America dominated the market in 2022 with the largest revenue share of 38.0% due to the high penetration of novel cosmetic treatments. In addition, dermatologists in this region are developing new non-surgical cosmetic procedures and hyaluronidase-based injectables which are among the highly recommended injectable dermal fillers
  • Asia Pacific is projected to witness the fastest growth owing to the numerous untapped growth opportunities in hyaluronidase-based treatments
  • A robust network of local manufacturers has significantly contributed to the revenue generated from this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hyaluronidase Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Hyaluronidase Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Hyaluronidase: Type Estimates & Trend Analysis

  • 4.1. Hyaluronidase Market: Key Takeaways
  • 4.2. Hyaluronidase Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Animal-derived hyaluronidase
    • 4.3.1. Animal-derived hyaluronidase market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Synthetic hyaluronidase
    • 4.4.1. Synthetic hyaluronidase market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hyaluronidase: Application Estimates & Trend Analysis

  • 5.1. Hyaluronidase Market: Key Takeaways
  • 5.2. Hyaluronidase Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Dermatology
    • 5.3.1. Dermatology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Chemotherapy
    • 5.4.1. Chemotherapy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Ophthalmology
    • 5.5.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Plastic Surgery
    • 5.6.1. Plastic Surgery market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Hyaluronidase Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Hyaluronidase Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Amphastar Pharmaceuticals, Inc.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. PrimaPharma, Inc.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Halozyme, Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Bausch & Lomb Incorporated
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. The Cooper Companies Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Sun Pharmaceutical Industries Ltd.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. STEMCELL Technologies Inc.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Shreya Life Sciences Pvt. Ltd.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 7 Canada hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 9 Europe hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 10 Europe hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 11 Europe hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 14 UK hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 16 France hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 17 France hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 18 Italy hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 20 Spain hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 22 Sweden hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 23 Sweden hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 24 Norway hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 25 Norway hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 26 Denmark hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 27 Denmark hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 31 China hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 32 China hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 33 Japan hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 34 Japan hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 35 India hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 36 India hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 37 Australia hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 38 Australia hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 39 Thailand hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 40 Thailand hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 41 South Korea hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 42 South Korea hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 43 Latin America hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 44 Latin America hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 45 Latin America hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 48 Mexico hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 50 Argentina hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 59 UAE hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 61 Kuwait hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait hyaluronidase market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Hyaluronidase: Market outlook
  • Fig. 9 Hyaluronidase: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Hyaluronidase market driver impact
  • Fig. 15 Hyaluronidase market restraint impact
  • Fig. 16 Hyaluronidase market strategic initiatives analysis
  • Fig. 17 Hyaluronidase market: Type movement analysis
  • Fig. 18 Hyaluronidase market: type outlook and key takeaways
  • Fig. 19 Animal derived hyaluronidase market estimates and forecasts, 2018 - 2030
  • Fig. 20 Synthetic hyaluronidase market estimates and forecasts, 2018 - 2030
  • Fig. 21 Hyaluronidase market: Application movement analysis
  • Fig. 22 Hyaluronidase market: Application outlook and key takeaways
  • Fig. 23 Dermatology market estimates and forecasts, 2018 - 2030
  • Fig. 24 Chemotherapy market estimates and forecasts, 2018 - 2030
  • Fig. 25 Ophthalmology market estimates and forecasts, 2018 - 2030
  • Fig. 26 Plastic surgery market estimates and forecasts, 2018 - 2030
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030
  • Fig. 28 Global Hyaluronidase market: Regional movement analysis
  • Fig. 29 Global Hyaluronidase market: Regional outlook and key takeaways
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 33 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 34 UK market estimates and forecasts, 2018 - 2030
  • Fig. 35 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 36 France market estimates and forecasts, 2018 - 2030
  • Fig. 37 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 38 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 39 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 40 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 41 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 42 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 43 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 44 China market estimates and forecasts, 2018 - 2030
  • Fig. 45 India market estimates and forecasts, 2018 - 2030
  • Fig. 46 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 49 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 50 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 51 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 53 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 54 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 55 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030